IL17 and IL-23 levels have been determined patients who have RR- serum MS

Tasdemir, N.2024-04-242024-04-2420170022-510X1878-5883https://doi.org/10.1016/j.jns.2017.08.3205https://hdl.handle.net/11468/1569123rd World Congress of Neurology (WCN) -- SEP 16-21, 2017 -- Kyoto, JAPAN[Abstract Not Available]eninfo:eu-repo/semantics/closedAccess[No Keyword]IL17 and IL-23 levels have been determined patients who have RR- serum MSIL17 and IL-23 levels have been determined patients who have RR- serum MSConference Object38111381138WOS:00042745030440310.1016/j.jns.2017.08.3205Q3